Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multi-center Post Authorization Surveillance Study on the Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice (IPASS Nebido)

NCT00410306 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00410306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00410306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multi-center Post Authorization Surveillance Study on the Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice (IPASS Nebido)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2010
Enrollment
1,493 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male